6-APBD | |
---|---|
Molecular structure via molpic | |
Conformer structure via 3Dmol.js | |
Molecular formula | C11H15NO[1] |
Molecular mass | 177.24 g/mol[1] |
Predicted LogP | 1.7[1] |
Chirality | racemic[2] |
Identifiers [] | |
---|---|
IUPAC name | 1-(2,3-dihydro-1-benzofuran-6-yl)propan-2-amine[1] |
SMILES | CC(CC1=CC2=C(CCO2)C=C1)N[1] |
InChI | InChI=1S/C11H15NO/c1-8(12)6-9-2-3-10-4-5-13-11(10)7-9/h2-3,7-8H,4-6,12H2,1H3[1] |
InChIKey | VRNGXHJGMCJRSQ-UHFFFAOYSA-N[1] |
Dosing |
---|
6-APBD
6-APBD (also known as 6-(2-Aminopropyl)-2,3-dihydrobenzofuran, 6-APDB, J3.334.443k, 6-Benzofuranethanamine, 2,3-dihydro-α-methyl-, (+-)-, 6-Nprop-dbf, 4-Desoxy-MDA, EMA-3, 6-Benzofuranethanamine,2,3-dihydro-a-methyl-, 6-(2-aminopropyl)2,3-dihydrobenzofuran or 6-Benzofuranethanamine, 2,3-dihydro-α-methyl-, (+/-)-) is a substance of the amphetamine class.
Chemistry
Stereochemistry
(RS)-6-APBD is a racemic mixture of the optical stereoisomers
Legal status
- Canada: 6-APBD is a Schedule I substance.
- Germany: 6-APBD is a Neuer-Psychoaktiver-Stoff under the "Neue-psychoaktive-Stoffe-Gesetz (NpSG)".
- United Kingdom: 6-APBD is a Class B substance.